BSECompany Update4d ago · 20 Sept 2026, 11:41 pm
Intimation of Analyst/Investor Meeting is enclosed.
Supriya Lifescience Ltd · 543434
✦ AI SummaryMgmt Change
Supriya Lifescience Ltd has announced an analyst/investor meeting on September 25, 2026, and has uploaded the investor presentation on its website and stock exchanges.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
92db9aa4-1f34-44a4-93bc-eec5cadb196f.pdf
View document text
September 20, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block,
Dalal Street, Bandra-Kurla Complex
Mumbai- 400 001 Bandra (E), Mumbai - 400 051
Scrip Code: 543434 NSE Symbol: SUPRIYA
Dear Sir/Madam,
Subject: Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing
Obligations and Disclosure Requirements), Regulations 2015
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the
officials of our Company, Supriya Lifescience Limited (“Company”) will be interacting with
Analyst/Institutional Investors as per details below:
Sr. Meeting with Date & Time Format Mode
1. Investors Group Meeting Friday, September 25, 2026 Group Meeting Virtual
11:00 AM – 12:00 Noon.
This is to further inform you that the copy of the Investor Presentation has been uploaded on the Stock
Exchanges and on the Company’s website www.supriyalifescience.com for your information and for the
information of your members and the public at large.
This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board
of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.
Note: The above date is subject to change. Change may happen due to exigencies on the part of the
Company or Analyst/Investor/Fund.
Request you to kindly take the same on record.
Thanking you,
For Supriya Lifescience Limited
Prachi Sathe
Company Secretary & Compliance Officer
Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India.
Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX
CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com
Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India.
Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com
GOVT. RECOGNISED EXPORT HOUSE